Vertex Pharmaceuticals Incorporated
Net Cash Flow Breakdown
Total Cash from Operations: $2.56B
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $0 | 0.0% |
| Other Investing | $0 | 0.0% |
| Stock Repurchases | $350.0M | 13.6% |
| Working Capital | $1.22B | 47.7% |
| Net Cash Flow | $990.7M | 38.6% |